June 16 – Health Canada – Press Release
Health Canada has requested that Canadian importers voluntarily quarantine drug products with active pharmaceutical ingredients (APIs) manufactured or tested by Zhejiang Hisun Pharma Company Ltd., in Zhejiang, China, due to data integrity concerns. Health Canada is taking this interim precautionary measure to help mitigate any potential risk in light of recent findings from a trusted … Read more